Cullinan Therapeutics, Inc.CGEMNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +36.51% | +36.89% | +36.95% | +7.20% | +1.16% |
| Weighted Average Shares Diluted Growth | +36.51% | +36.89% | +36.95% | +7.20% | +1.16% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +32.05% | +28.43% | +28.98% | -23.62% | -25.89% |
| Book Value per Share Growth | -1.90% | -4.95% | -5.34% | -30.04% | -28.94% |
| Debt Growth | -58.65% | -40.08% | -41.94% | -44.44% | -51.43% |
| R&D Expense Growth | +4.98% | +16.20% | +35.28% | +68.32% | +18.20% |
| SG&A Expenses Growth | +21.55% | +37.84% | +10.35% | +7.87% | +2.08% |